Arrowhead Pharmaceuticals Refinances Debt With $400 Million Loan Due 2031

Arrowhead used the fully funded senior secured term loan from Sixth Street Lending Partners and other lenders, together with cash on hand, to repay approximately $404.4 million of prior loans.